Proteasome Inhibitors (PI), Carfilzomib Maintenance, Relapsed Refractory Multiple Myeloma (RRMM), 1 prior line of therapy, No Maintenance, Phase 2
### Instruction:
Identify the study with the following condition. 
### Input:
Proteasome Inhibitors (PI), Carfilzomib Maintenance, Relapsed Refractory Multiple Myeloma (RRMM), 1 prior line of therapy, No Maintenance, Phase 2 
### Output:
Popular Name is MUK Five, Study ID is ISRCTN17354232